Chang Gung Study: Lipoprotein(a) Poses Higher Cardiovascular Risk than LDL for Asians
NQ Score
81/100
Key facts
- Chang Gung Study: Lipoprotein(a) Poses Higher Cardiovascular Risk than LDL for Asians
- A large-scale study by Linkou Chang Gung Memorial Hospital highlights the need for Asian-specific Lipoprotein(a) diagnostic thresholds, revealing that health risks increase at lower levels compared to Western populations.
- Source: CNA
- Date: Thu Jun 18 2026 16:02:00 GMT+0900 (Japan Standard Time)
Direct answer
A large-scale study by Linkou Chang Gung Memorial Hospital highlights the need for Asian-specific Lipoprotein(a) diagnostic thresholds, revealing that health risks increase at lower levels compared to Western populations.
- Citation
- Chang Gung Study: Lipoprotein(a) Poses Higher Cardiovascular Risk than LDL for Asians (Thu Jun 18 2026 16:02:00 GMT+0900 (Japan Standard Time)), CNA
- Source
- CNA
- Date
- Thu Jun 18 2026 16:02:00 GMT+0900 (Japan Standard Time)
AI Summary (NQ-processed)
A large-scale study by Linkou Chang Gung Memorial Hospital highlights the need for Asian-specific Lipoprotein(a) diagnostic thresholds, revealing that health risks increase at lower levels compared to Western populations.
AI analysis data is not yet available.
Frequently Asked Questions
- Q: Why is Lipoprotein(a) considered more dangerous than LDL?
- A: Lp(a) contains an additional protein chain called apolipoprotein(a), which increases its potential to cause inflammation and blood clots compared to standard low-density lipoprotein.
- Q: What is the new recommended risk threshold for the Asian population?
- A: The study suggests that the risk threshold for Asians starts at 30 mg/dL, which is lower than the 50 mg/dL standard commonly used in Western medical guidelines.
- Q: Can common cholesterol medications lower Lp(a) levels?
- A: Currently, most standard LDL-lowering drugs are not effective at significantly reducing Lp(a) concentrations, making it a primary source of residual cardiovascular risk.